Cargando…
Case report: Drug reaction with eosinophilia and systemic symptoms (DRESS)-induced hemophagocytic disorder
Hemophagocytic disorders are severe and life-threatening conditions that can be genetic in origin [i.e., primary hemophagocytic lymphohistiocytosis (HLH)] or result from infections (i.e., secondary hemophagocytic lymphohistiocytosis), rheumatologic disease [i.e., macrophage activation syndrome (MAS)...
Autores principales: | Pope, Eliza I., Au, Hosanna, Levy, Deborah M., Verstegen, Ruud H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681788/ https://www.ncbi.nlm.nih.gov/pubmed/36438790 http://dx.doi.org/10.3389/fphar.2022.1023522 |
Ejemplares similares
-
First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroids
por: Verstegen, Ruud H. J., et al.
Publicado: (2023) -
Drug reaction with eosinophilia and systemic symptoms (DRESS) in children
por: Francesca, Mori, et al.
Publicado: (2019) -
Griseofulvin associated with drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Maiolo, Corinne, et al.
Publicado: (2016) -
Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Sharpe, Alexis, et al.
Publicado: (2019) -
Valproate-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Dwivedi, Arun Kumar, et al.
Publicado: (2018)